Patients with PD-L1 positive tumours (≥1%) had worse survival when compared to patient with PD-L1 negative (<1%) tumours (HR 1.581 CI 1.043–2.396, p = 0.031, Fig. 2E). This evidence concerns the gene CD274 and neoplasm.